BRPI0512086A - composto e os sais farmacologicamente aceitáveis do mesmo, composição farmacêutica, e, processo para a preparação de compostos - Google Patents
composto e os sais farmacologicamente aceitáveis do mesmo, composição farmacêutica, e, processo para a preparação de compostosInfo
- Publication number
- BRPI0512086A BRPI0512086A BRPI0512086-1A BRPI0512086A BRPI0512086A BR PI0512086 A BRPI0512086 A BR PI0512086A BR PI0512086 A BRPI0512086 A BR PI0512086A BR PI0512086 A BRPI0512086 A BR PI0512086A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- acceptable salts
- compound
- preparation
- pharmaceutically acceptable
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- NXOVZLREWXNIDP-UHFFFAOYSA-N 7h-pyrazino[2,3-c]carbazole Chemical class N1=CC=NC2=C3C4=CC=CC=C4NC3=CC=C21 NXOVZLREWXNIDP-UHFFFAOYSA-N 0.000 abstract 1
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 101100294115 Caenorhabditis elegans nhr-4 gene Proteins 0.000 abstract 1
- 125000005055 alkyl alkoxy group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 abstract 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Abstract
COMPOSTO E OS SAIS FARMACOLOGICAMENTE ACEITáVEIS DO MESMO, COMPOSIçãO FARMACêUTICA, E, PROCESSO PARA A PREPARAçãO DE COMPOSTOS Indoloquinoxalinas substituídas novas da fórmula (IR¬ 2¬ (I)¬ Y¬ onde R¬ 1¬ é hidrogênio ou representa um ou mais substituintes semelhantes ou diferentes nas posições 7 a 10 escolhidos do grupo de halogênio, alquil/alcóxi inferior, hidróxi, trifluorometila, triclorometila, trifluorometóxi, R¬ 2¬ representa alquil substituintes C~ 1~ -C~ 4~ semelhantes ou diferentes, X é CO ou CH~ 2~, Y é OH, NH~ 2~, NH-(CH~ 2~)~ n~ -R¬ 3¬ onde R¬ 3¬ representa alquila inferior, OH, NH~ 2~, NHR¬ 4¬ ou NR¬ 5¬ R¬ 6¬ onde R¬ 4¬, R¬ 5¬ e R¬ 6¬, independentemente, são alquila ou cicloalquila inferior e n é um número inteiro de 2 a 4, com a condição de que quando X é CH~ 2~, Y é OH ou NH-(CH~ 2~)~ n~ -OH, e os sais farmacologicamente aceitáveis dos mesmos, são descritos. Os compostos são úteis como drogas para evitar e/ou tratar doenças autoimunes.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0401555A SE527639C2 (sv) | 2004-06-17 | 2004-06-17 | Alkylsubstituerade indolokinoxaliner |
| PCT/SE2005/000718 WO2005123741A1 (en) | 2004-06-17 | 2005-05-18 | Alkyl substituted indoloquinoxalines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0512086A true BRPI0512086A (pt) | 2008-02-06 |
Family
ID=32710074
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0512086-1A BRPI0512086A (pt) | 2004-06-17 | 2005-05-18 | composto e os sais farmacologicamente aceitáveis do mesmo, composição farmacêutica, e, processo para a preparação de compostos |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US7589093B2 (pt) |
| EP (1) | EP1756111B1 (pt) |
| JP (1) | JP5038891B2 (pt) |
| CN (1) | CN1976934B (pt) |
| AT (1) | ATE462707T1 (pt) |
| AU (1) | AU2005254919B2 (pt) |
| BR (1) | BRPI0512086A (pt) |
| CA (1) | CA2568592C (pt) |
| CY (1) | CY1110145T1 (pt) |
| DE (1) | DE602005020283D1 (pt) |
| DK (1) | DK1756111T3 (pt) |
| ES (1) | ES2342946T3 (pt) |
| IL (1) | IL179171A (pt) |
| MX (1) | MXPA06014170A (pt) |
| NO (1) | NO20070289L (pt) |
| NZ (1) | NZ551780A (pt) |
| PL (1) | PL1756111T3 (pt) |
| PT (1) | PT1756111E (pt) |
| RU (1) | RU2369609C2 (pt) |
| SE (1) | SE527639C2 (pt) |
| SI (1) | SI1756111T1 (pt) |
| WO (1) | WO2005123741A1 (pt) |
| ZA (1) | ZA200700358B (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE529777C2 (sv) * | 2006-01-23 | 2007-11-20 | Vironova Ab | Nya föreningar och användning därav |
| JP5454750B2 (ja) | 2008-03-05 | 2014-03-26 | 東洋製罐株式会社 | 缶詰の内圧検査方法及びその装置 |
| ATE473977T1 (de) | 2008-04-30 | 2010-07-15 | Univ Duisburg Essen | Indolä2,3-bü-, indenä1,2-bü- und indenä2,1- büpyridoä2,3-fü quinoxalin-3-carboxylsäuren und ester, verfahren zu ihrer herstellung und ihre verwendung als antivirus- und antitumormittel |
| EP2489354A1 (en) * | 2011-02-18 | 2012-08-22 | Vironova AB | Pharmaceutical formulation of B220 for topical treatment of herpes |
| CN103211960B (zh) * | 2012-01-18 | 2017-10-13 | 金士力佳友(天津)有限公司 | 具有降血糖作用的中药组合物、其应用及制备方法 |
| HK1220196A1 (zh) * | 2013-03-15 | 2017-04-28 | Vironova Herpes Ab | 抗病毒吲哚并[2，3-b]喹喔啉 |
| AU2021289006A1 (en) * | 2020-06-10 | 2023-02-09 | Cyxone Ab | Method for preparing a crystalline form of rabeximod |
| WO2021250196A1 (en) * | 2020-06-10 | 2021-12-16 | Cyxone Ab | New use of rabeximod |
| CA3191963A1 (en) | 2020-09-21 | 2022-03-24 | Jan Bergman | Thionoester-derivative of rabeximod for the treatment of inflammatory and autoimmune disorders |
| US11643415B1 (en) | 2021-12-09 | 2023-05-09 | Cyxone Ab | Rabeximod compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE504862C2 (sv) * | 1994-12-27 | 1997-05-20 | Leif J I Lundblad | Användning av vissa indolo-§2,3b¤-kinoxaliner för framställning av ett läkemedel för skydd av DNA i initieringsfasen och/eller promotionsfasen av karcinogenes och för förhindrande av oxidativ stress i patienter med sjukdomar relaterade till fria radikaler |
| US6333327B2 (en) * | 2000-02-18 | 2001-12-25 | Leif J. I. Lundblad | Method for the treatment of Multiple Sclerosis |
| SE516067C2 (sv) * | 2000-02-18 | 2001-11-12 | Lundblad Leif J I | Användning av en förening för framställning av ett läkemedel |
-
2004
- 2004-06-17 SE SE0401555A patent/SE527639C2/sv not_active IP Right Cessation
-
2005
- 2005-05-18 RU RU2007101497/04A patent/RU2369609C2/ru active
- 2005-05-18 US US11/143,935 patent/US7589093B2/en active Active
- 2005-05-18 DK DK05742482.2T patent/DK1756111T3/da active
- 2005-05-18 ES ES05742482T patent/ES2342946T3/es not_active Expired - Lifetime
- 2005-05-18 CN CN200580019227XA patent/CN1976934B/zh not_active Expired - Lifetime
- 2005-05-18 JP JP2007516422A patent/JP5038891B2/ja not_active Expired - Lifetime
- 2005-05-18 SI SI200531030T patent/SI1756111T1/sl unknown
- 2005-05-18 PT PT05742482T patent/PT1756111E/pt unknown
- 2005-05-18 WO PCT/SE2005/000718 patent/WO2005123741A1/en not_active Ceased
- 2005-05-18 EP EP05742482A patent/EP1756111B1/en not_active Expired - Lifetime
- 2005-05-18 NZ NZ551780A patent/NZ551780A/en not_active IP Right Cessation
- 2005-05-18 DE DE602005020283T patent/DE602005020283D1/de not_active Expired - Lifetime
- 2005-05-18 AU AU2005254919A patent/AU2005254919B2/en not_active Ceased
- 2005-05-18 ZA ZA200700358A patent/ZA200700358B/xx unknown
- 2005-05-18 CA CA2568592A patent/CA2568592C/en not_active Expired - Fee Related
- 2005-05-18 MX MXPA06014170A patent/MXPA06014170A/es active IP Right Grant
- 2005-05-18 PL PL05742482T patent/PL1756111T3/pl unknown
- 2005-05-18 AT AT05742482T patent/ATE462707T1/de active
- 2005-05-18 BR BRPI0512086-1A patent/BRPI0512086A/pt not_active IP Right Cessation
-
2006
- 2006-11-09 IL IL179171A patent/IL179171A/en not_active IP Right Cessation
-
2007
- 2007-01-16 NO NO20070289A patent/NO20070289L/no not_active Application Discontinuation
-
2009
- 2009-07-01 US US12/496,261 patent/US8084453B2/en not_active Expired - Lifetime
-
2010
- 2010-06-29 CY CY20101100598T patent/CY1110145T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1110145T1 (el) | Αλκυλο-υποκατεστημενες ινδολοκινοξαλινες | |
| CY1122863T1 (el) | Φαρμακευτικη συνθεση που περιεχει γλυκοπυρρολικο και εναν αγωνιστη βητα2 αδρενοϋποδοχεα | |
| ATE437872T1 (de) | Proteinkinaseinhibitoren | |
| DK1412354T3 (da) | Derivater af triazolylimidazopyridin og af triazolylpurinerne, der er egnede som ligander for adenosin A2a?-receptoren og deres anvendelse som medikamenter | |
| DE602007004851D1 (de) | A2a-adenosin-rezeptor-antagonisten | |
| MX340965B (es) | Combinaciones para el tratamiento de enfermedades que involucran la proliferacion celular. | |
| CA2545427A1 (en) | Selective kinase inhibitors | |
| SG128491A1 (en) | Heterocyclic sulfonamide inhibitors of beta amyloid production | |
| ATE471323T1 (de) | Purinderivate als antagonisten an purinergen rezeptoren | |
| CL2004000382A1 (es) | Tetrahidroisoquinolinas sustituidas, proceso de preparacion, y composicion farmaceutica, utiles en el tratamiento y prevencion de estados patologicos que se alivian con un agonista de 5-ht6. | |
| BRPI0608732A2 (pt) | composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto | |
| SE0401342D0 (sv) | Therapeutic compounds | |
| ECSP066948A (es) | Benzoxazinas para el tratamiento de enfermedades de las vías respiratorias | |
| ATE435223T1 (de) | Pyrimidin-, chinazolin-, pteridin- und triazinderivate | |
| EA200700901A1 (ru) | Производные 2-амидо-4-фенилтиазола, их получение и применение в терапии | |
| CY1108632T1 (el) | Παραγωγα της 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline για θεραπεια της στειροτητας | |
| HRP20080119T5 (en) | Benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same | |
| AR044175A1 (es) | Compuestos de cefemo | |
| PE20060355A1 (es) | TIENO[3,2-b]PIRIDIN-6-CARBONITRILOS COMO INHIBIDORES DE LA QUINASA PROTEICA | |
| RU2003113145A (ru) | Замещенные 5r1, 6r2-1, 3,4-тиадиазин-2, амины и содержащие их фармацевтические композиции в качестве фармакологически активных средств, обладающих антикоагулятным и антиагрегатным действием | |
| TW200626567A (en) | Benzoxazine and quinoxaline derivatives and uses | |
| HRP20030713B1 (en) | Imidazolidine derivatives their preparation, and their use as antiflamatory agent | |
| BRPI0513549A (pt) | composições farmacêuticas para o tratamento de leishmaniose | |
| WO2006029075A3 (en) | Fibrate compounds having ppar agonist activity | |
| TW200614991A (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015. |